Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Short Bowel Syndrome
Interventions
DRUG:
Teduglutide 0.05mg/kg
DRUG:
Teduglutide 0.025 mg/kg
OTHER:
Standard of Care
Sponsor
Shire